Gemcitabine for Marginal Zone Lymphoma

Summary

Marginal zone lymphoma, one of the indolent lymphoma, is believed to be incurable with chemotherapy. Thus the investigators need a novel agent for marginal zone lymphoma. Gemcitabine has been tried as one of salvage chemotherapy regimen and has been shown to have anti-lymphoma activity. To the investigators' knowledge, there has been no trial of gemcitabine for marginal zone lymphoma. Thus the investigators made a plan to investigate the role of gemcitabine in marginal zone lymphoma.

Timeline

Start

2006-06

Primary completion

2009-03

Completion

2009-03

Outcome

Outcome not reported

Stopped (Enrollment): “poor accrual and response less than expected on interim analysis”

Drugs

Indications